Roche diagnoses' LumiraDX Rapid Tests are designed to be used with the LumiraDX platform, providing quick and accurate diagnoses right at the point of need. The tests can be completed in a few steps, saving healthcare workers considerable time throughout their daily routine because of the straightforward sample collection and minimum hands-on time.
Well-founded clinical decision-making is supported by the availability of accurate results in a matter of minutes. Numerous markers, including CRP, D-Dimer, INR, HbA1c, and NT-proBNP, can be tested.
Product Details
- LumiraDX Rapid Test from Roche Diagnostics
- Specifically designed for the LumiraDX PoC system
- Quick test procedure in just a few steps
- Delivers reliable results within minutes
- Minimal hands-on time saves valuable resources
- Especially simple sample collection
- Matching quality control available
- Available for various parameters
- Excluded from return policy
- For professional in-vitro diagnostics only
| |
CRP |
D-Dimer |
INR |
HbA1c |
NT-proBNP |
| Sample Type |
Capillary blood Plasma* Whole blood* |
Capillary blood Plasma** Whole blood** |
Capillary blood |
Capillary blood Whole blood*** |
Capillary blood Plasma* Whole blood* |
| Sample Volume |
20 μl |
15 μl |
8 μl |
15 μl |
20 μl |
| Test Duration |
4 minutes |
6 minutes |
< 90 seconds |
5 minutes |
12 minutes |
| Precision |
< 10% CV |
≤ 11.1% CV |
< 3.73% CV |
≤ 4% CV |
≤ 12% CV |
| Measuring Range |
5.0–250.0 mg/l |
190–4000 μg/l FEU |
0.8–80 INR |
20–130 mmol/mol |
50–9000 pg/ml (ng/l) |
| Haematocrit |
15–55% |
20–55% |
25–55% |
6–21 g/dl |
15–55% |
| Transfer Tube |
Lithium heparin |
Lithium heparin |
Without anticoagulant |
|
Lithium heparin |
| Storage Temperature |
2–30 °C |
2–30 °C |
5–32 °C |
2–30 °C |
2–30 °C |
| Contents |
24 tests |
12 tests |
48 tests |
24 tests |
12 tests |
*Lithium heparin
**Sodium citrate
***EDTA
The LumiraDx HbA1c Test can be used to help screening for diabetes risk assessment as well as long-term blood glucose monitoring in people with diabetes. The capacity to monitor HbA1c offers important information for clinical decision-making about the right level of therapy intensification.